Abstract
The most common cancer for women in the United Kingdom is breast cancer and it is well known that genomic modifications are responsible for breast carcinogenesis. Major developments in genomics and proteomics have uncovered biomarkers which have a crucial role in this process. To move towards individualized and improved breast cancer care, there is a need for tumor markers that are associated with disease diagnosis, prognosis, treatment and monitoring. General opinion is that biomarkers can bring more accurate and sensitive tools to the clinical settings than conventional approved histopathological parameters. However, clinical applications of breast tumor markers remain quite low in numbers because the data regarding these novel markers for breast cancer is limited and do not allow well-grounded conclusions. This review presents a non exhaustive selection of biomarkers published, some validated, and their uses in breast cancer management.
Keywords: Breast cancer, tumor markers, diagnosis, prognosis, therapy, NPI
Current Cancer Therapy Reviews
Title: Emerging Breast Cancer Biomarkers
Volume: 4 Issue: 2
Author(s): Stephanie A. Laversin, Amanda K. Miles, Graham R. Ball and Robert C. Rees
Affiliation:
Keywords: Breast cancer, tumor markers, diagnosis, prognosis, therapy, NPI
Abstract: The most common cancer for women in the United Kingdom is breast cancer and it is well known that genomic modifications are responsible for breast carcinogenesis. Major developments in genomics and proteomics have uncovered biomarkers which have a crucial role in this process. To move towards individualized and improved breast cancer care, there is a need for tumor markers that are associated with disease diagnosis, prognosis, treatment and monitoring. General opinion is that biomarkers can bring more accurate and sensitive tools to the clinical settings than conventional approved histopathological parameters. However, clinical applications of breast tumor markers remain quite low in numbers because the data regarding these novel markers for breast cancer is limited and do not allow well-grounded conclusions. This review presents a non exhaustive selection of biomarkers published, some validated, and their uses in breast cancer management.
Export Options
About this article
Cite this article as:
Laversin A. Stephanie, Miles K. Amanda, Ball R. Graham and Rees C. Robert, Emerging Breast Cancer Biomarkers, Current Cancer Therapy Reviews 2008; 4 (2) . https://dx.doi.org/10.2174/157339408784310179
DOI https://dx.doi.org/10.2174/157339408784310179 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Rho-kinase (ROCK) Inhibitors - A Neuroprotective Therapeutic Paradigm with a Focus on Ocular Utility
Current Medicinal Chemistry Role of Amygdalin in Blocking DNA Replication in Breast Cancer In Vitro
Current Pharmaceutical Biotechnology Editorial (Thematic Issue: Vaccines)
Recent Patents on Inflammation & Allergy Drug Discovery Role of FoxM1 in the Progression and Epithelial to Mesenchymal Transition of Gastrointestinal Cancer
Recent Patents on Anti-Cancer Drug Discovery miR-135a Suppresses Calcification in Senescent VSMCs by Regulating KLF4/STAT3 Pathway
Current Vascular Pharmacology Synthesis and Biological Activity of Some New N1-(4-oxoquinolin-6-yl) amidrazones
Letters in Organic Chemistry Systemic Drug Delivery Systems for Bone Tissue Regeneration– A Mini Review
Current Pharmaceutical Design Neuromodulators and Therapeutic Targets in Neuropathic Pain: From Molecules to Man
CNS & Neurological Disorders - Drug Targets Synthesis of Novel Fused Regioisomeric Oxetane Bicycles via Paternò-Büchi Reaction of L-Ascorbic Acid and Evaluation as Antiproliferative Agents
Current Organic Synthesis Recent Advances in Superparamagnetic Iron Oxide Nanoparticles for Cellular Imaging and Targeted Therapy Research
Current Pharmaceutical Design Smart Drug-Delivery Systems for Cancer Nanotherapy
Current Drug Targets Raloxifene and Cardiovascular Health: Its Relationship to Lipid and Glucose Metabolism, Hemostatic and Inflammation Factors and Cardiovascular Function in Postmenopausal Women
Current Pharmaceutical Design Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn’s Disease and Ulcerative Colitis
Current Pharmaceutical Design Thiol Proteases: Inhibitors and Potential Therapeutic Targets
Current Medicinal Chemistry Editorial [Hot Topic:Recent Advances in Developmental and Reproductive Toxicology (Executive Editor: Gian Mario Tiboni )]
Current Pharmaceutical Design Low-Dose Methotrexate (LD-MTX) in Rheumatology Practice - A Most Widely Misunderstood Drug
Current Rheumatology Reviews IgA/IgM Responses to Gram-Negative Bacteria are not Associated with Perinatal Depression, but with Physio-somatic Symptoms and Activation of the Tryptophan Catabolite Pathway at the End of Term and Postnatal Anxiety
CNS & Neurological Disorders - Drug Targets The Critical Roles of HSC70 in Physiological and Pathological Processes
Current Pharmaceutical Design Tyrosine Hydroxylase Gene: Another Piece of the Genetic Puzzle of Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Oxidative Stress in the Cochlea: An Update
Current Medicinal Chemistry